多发性硬化症患者的最终COVID-19疫苗接种情况,态度和不良事件:来自埃及的跨部门研究
Eman Hamdy1, Eman Hamdy Darweesh2, Abdallah Dabbas3
1From the Department of Neurology, Alexandria University, Alexandria, Egypt.
International journal of MS care
|March 12, 2025
概括
在埃及,许多患有多发性硬化症 (MS) 的人避免接种COVID-19疫苗,因为担心会使他们的病情恶化. 不良事件是轻微的,突出了提高MS疫苗接种率的教育计划的必要性.
科学领域:
- 神经学 神经学
- 免疫学 免疫学 免疫学
- 公共卫生 公共卫生
背景情况:
- 在世卫组织宣布2023年全球卫生紧急情况结束之前,患有多发性硬化症 (MS) 的人群中普遍存在对COVID-19疫苗接种的犹.
- 对疫苗对多发性硬化症进展和长期不良事件 (AE) 影响的担忧导致了疫苗的犹.
研究的目的:
- 评估埃及MS患者中COVID-19疫苗接种情况.
- 评估人们对COVID-19疫苗接种的态度,并确定该人群中报告的不良事件.
主要方法:
- 一个自我管理的调查分发给参加亚历山大大学MS诊所的MS患者.
- 在2023年6月至2023年11月期间,从150名参与者收集了数据.
主要成果:
- 只有54%的参与者接种了COVID-19疫苗,81.5%完成了两剂.
- 对COVID-19 (FCV-19S) 的恐惧与接种疫苗状态有显著的关联 (P = .049).
- 最常见的副作用是疲劳 (48%),5%的人经历了神经复发;没有报告严重的副作用.
结论:
- 几乎一半的MS研究参与者仍然没有接种COVID-19疫苗,主要是因为害怕.
- 与疫苗相关的副作用通常是轻微的,这表明了有利的安全性.
- 在未来的健康危机期间,教育举措对于提高MS患者在COVID-19疫苗接种率至关重要.
相关概念视频
01:51Vaccinations
Overview
01:15Bioavailability Study Design: Healthy Subjects Versus Patients
Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
01:19Multiple Sclerosis l: Introduction
Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...